Science and Innovation Stories

Targeting Obesity Using Biology, Not Behavior

Leveraging expertise in human genetics and biology, Amgen is developing multispecific medicines that target obesity, a complex biological disease with multiple underlying causes.

All Stories <i class="fa fa-angle-down"></i><i class="fa fa-angle-up"></i>

Load more